Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
14,217,470
-
Share change
-
+831,921
-
Total reported value
-
$1,025,670,608
-
Put/Call ratio
-
140%
-
Price per share
-
$72.15
-
Number of holders
-
103
-
Value change
-
+$62,635,909
-
Number of buys
-
55
-
Number of sells
-
49
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q1 2016
As of 31 Mar 2016,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,217,470 shares.
The largest 10 holders included
Capital Research Global Investors, FMR LLC, PRUDENTIAL PLC, Bank of New York Mellon Corp, JANUS CAPITAL MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, DEERFIELD MANAGEMENT CO, Point72 Asset Management, L.P., FEDERATED INVESTORS INC /PA/, and MILLENNIUM MANAGEMENT LLC.
This page lists
103
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.